semaglutide news oct 26 2025 A new study suggests GLP-1s could have a much greater impact beyond obesity and could be tailored to the individual. Learn more at the link in our bio When Joshua Hunt (@viajoshhunt) started

En personas con obesidad, prdida de peso agresiva, edad avanzada o bajo apetito por tratamiento con GLP-1, esta parte se vuelve todava ms importante

October 29, 2025

No, Ozempic is not designed to be an alternative to Insulin

*Correspondence: JianQing Zhou [email protected] This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

According to FDA safety communications, patients should ask their provider or compounder how to measure and administer the intended dose